Jun 16, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Impax Laboratories Confirms Patent Challenge Relating To WELCHOL(R) 625 Mg Tablets
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2079235" data-attributes="member: 124445"><p>Impax Laboratories, Inc. (NASDAQ:IPXL) confirms that it has initiated a challenge of patents listed by Daiichi Sankyo, Inc. in connection with its WELCHOL® (Colesevelam HCl) tablets, 625 mg. Impax filed its Abbreviated New Drug Application ("ANDA") containing a paragraph IV certification for a generic version of WELCHOL® with the U.S. Food & Drug Administration ("FDA"). Following receipt of the notice from the FDA that Impax's ANDA had been accepted for filing, Impax notified the New Drug Application holder and patent owners of its paragraph IV certification...<a href="http://feedads.g.doubleclick.net/~a/SD409Trp4HVH2JFnsKXzxDG1OBU/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/SD409Trp4HVH2JFnsKXzxDG1OBU/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/SD409Trp4HVH2JFnsKXzxDG1OBU/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/SD409Trp4HVH2JFnsKXzxDG1OBU/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/SAip6nNlbM8" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/SAip6nNlbM8/3wsP" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2079235, member: 124445"] Impax Laboratories, Inc. (NASDAQ:IPXL) confirms that it has initiated a challenge of patents listed by Daiichi Sankyo, Inc. in connection with its WELCHOL® (Colesevelam HCl) tablets, 625 mg. Impax filed its Abbreviated New Drug Application ("ANDA") containing a paragraph IV certification for a generic version of WELCHOL® with the U.S. Food & Drug Administration ("FDA"). Following receipt of the notice from the FDA that Impax's ANDA had been accepted for filing, Impax notified the New Drug Application holder and patent owners of its paragraph IV certification...[URL="http://feedads.g.doubleclick.net/~a/SD409Trp4HVH2JFnsKXzxDG1OBU/0/da"][IMG]http://feedads.g.doubleclick.net/~a/SD409Trp4HVH2JFnsKXzxDG1OBU/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/SD409Trp4HVH2JFnsKXzxDG1OBU/1/da"][IMG]http://feedads.g.doubleclick.net/~a/SD409Trp4HVH2JFnsKXzxDG1OBU/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/SAip6nNlbM8[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/SAip6nNlbM8/3wsP]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top